The Nanomedical Market is expected to exceed more than US$ 450 Billion by 2028 at a CAGR of 10.3% in the given forecast period.
Nanomedicine market is mainly driven by increase in acceptance of nanomedicine across diverse applications, rise in government funding & support, emerging technologies for drug delivery, rise in need for therapies with less side effects and allergies, and cost-effectiveness of therapies.
Growing healthcare facilities in developing countries are anticipated to bring numerous opportunities for the growth of nanomedicine market.
Nanomedicine is one of the applications of nanotechnology used in treatment, monitoring, diagnosis, and control of biological systems. Nanomedicine utilizes nanoscale control of materials to improve medicine delivery. Subsequently, nanomedicine has encouraged treatment against different diseases.
The global Nanomedical market is segregated on the basis of Indication as Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, and Others. Based on Application the global Nanomedical market is segmented in Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines, and Others. Based on Modality the global Nanomedical market is segmented in Treatments and Diagnostics.
The global Nanomedical market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Nanomedical market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others are among the major players in the global Nanomedical market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Nanomedical Market has been segmented as below:
Nanomedical Market, By Indication
Nanomedical Market, By Application
Nanomedical Market, By Modality
Nanomedical Market, By Region
Nanomedical Market, By Company
The report covers:
Report Scope:
The global Nanomedical market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Nanomedical market share. Major industry players with significant revenue share include Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Nanomedical Market, By Indication
5.1 Introduction
5.2 Ophthalmological Diseases
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Immunological Diseases
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Cardiovascular Diseases
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Oncological Diseases
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Infectious Diseases
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Orthopedic Disorders
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Neurological Diseases
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Urological Diseases
5.9.1 Market Overview
5.9.2 Market Size and Forecast
5.10 Others
5.10.1 Market Overview
5.10.2 Market Size and Forecast
6. Nanomedical Market, By Application
6.1 Introduction
6.2 Implants
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Regenerative Medicine
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Diagnostic Imaging
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Drug Delivery
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Vaccines
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Others
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. Nanomedical Market, By Modality
7.1 Introduction
7.2 Treatments
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Diagnostics
7.3.1 Market Overview
7.3.2 Market Size and Forecast
8. Nanomedical Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Nanomedical, By Indication
8.2.2 North America Nanomedical, By Application
8.2.3 North America Nanomedical, By Modality
8.3 Europe
8.3.1 Europe Nanomedical, By Indication
8.3.2 Europe Nanomedical, By Application
8.3.3 Europe Nanomedical, By Modality
8.4 Asia-Pacific
8.4.1 Asia-Pacific Nanomedical, By Indication
8.4.2 Asia-Pacific Nanomedical, By Application
8.4.3 Asia-Pacific Nanomedical, By Modality
8.5 Rest of the World
8.5.1 Rest of the World Nanomedical, By Indication
8.5.2 Rest of the World Nanomedical, By Application
8.5.3 Rest of the World Nanomedical, By Modality
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Johnson & Johnson
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Mallinckrodt plc.
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Merck & Company, Inc.
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Nanosphere, Inc.
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Pfizer, Inc.
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Teva Pharmaceutical Industries Ltd.
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Abbott Laboratories
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 CombiMatrix Corporation
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 General electric Company
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Sigma-Tau Pharmaceuticals, Inc.
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Nanomedical Market has been segmented as below:
Nanomedical Market, By Indication
Nanomedical Market, By Application
Nanomedical Market, By Modality
Nanomedical Market, By Region
Nanomedical Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
